Skip to main content
Erschienen in: AIDS and Behavior 5/2024

29.02.2024 | Original Paper

Association of Alcohol Use with COVID-19 Infection and Hospitalization Among People Living with HIV in the United States, 2020

verfasst von: Chunyi Xia, Geetanjali Chander, Heidi E. Hutton, Mary E. McCaul, Joseph A. Delaney, Kenneth H. Mayer, Jeffrey M. Jacobson, Sarah Puryear, Heidi M. Crane, Adrienne E. Shapiro, Edward R. Cachay, Bryan Lau, Sonia Napravnik, Michael Saag, Catherine R. Lesko

Erschienen in: AIDS and Behavior | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Alcohol use was associated with elevated COVID-19 risk in the general population. People with HIV (PWH) have high prevalences of alcohol use. To evaluate the effect of alcohol use on COVID-19 risks among PWH, we estimated the risk of COVID-19 diagnosis and COVID-19-related hospitalization among PWH in routine care at 8 HIV primary care centers that contributed data to the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) cohort according to their alcohol use just prior to the COVID-19 pandemic. The CNICS data repository includes demographic characteristics, clinical diagnoses, and laboratory test results from electronic medical records and other sources. Alcohol use, substance use, and mental health symptoms were self-reported on tablet-based standardized surveys. Alcohol use was categorized according to standard, sex-specific Alcohol Use Disorder Identification Test-Consumption instrument cut-offs. We followed 5,496 PWH (79% male, 48% Black race, median age = 53 years) from March 1, 2020 to December 31, 2020. Relative to PWH with no baseline alcohol use, the adjusted hazard ratio (aHR) of COVID-19 diagnosis was 1.09 (95% confidence interval [CI]: 0.78, 1.51) for lower-risk drinking and 1.19 (95%CI: 0.81, 1.73) for unhealthy drinking. The aHR of COVID-19-related hospitalization was 0.82 (95%CI: 0.33, 1.99) for lower-risk drinking and 1.25 (95%CI: 0.50, 3.09) for unhealthy drinking. Results were not modified by recent cocaine or non-prescribed opioid use, depressive symptoms, or diagnoses of alcohol use disorder. The study suggested a slightly increased, but not statistically significant risk of COVID-19 diagnosis and hospitalization associated with unhealthy alcohol use.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Bailey KL, Sayles H, Campbell J, Khalid N, Anglim M, Ponce J, et al. COVID-19 patients with documented alcohol use disorder or alcohol-related complications are more likely to be hospitalized and have higher all-cause mortality. Alcoholism: Clin Experimental Res. 2022;46:1023–35.CrossRef Bailey KL, Sayles H, Campbell J, Khalid N, Anglim M, Ponce J, et al. COVID-19 patients with documented alcohol use disorder or alcohol-related complications are more likely to be hospitalized and have higher all-cause mortality. Alcoholism: Clin Experimental Res. 2022;46:1023–35.CrossRef
3.
Zurück zum Zitat Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2021;26:30–9.PubMedCrossRef Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2021;26:30–9.PubMedCrossRef
4.
Zurück zum Zitat Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. 2021;20:124–30.PubMedCrossRef Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. 2021;20:124–30.PubMedCrossRef
5.
Zurück zum Zitat Sigel K, Swartz T, Golden E, Paranjpe I, Somani S, Richter F, et al. Coronavirus 2019 and people living with Human Immunodeficiency Virus: outcomes for hospitalized patients in New York City. Clin Infect Dis. 2020;71:2933–8.PubMedPubMedCentralCrossRef Sigel K, Swartz T, Golden E, Paranjpe I, Somani S, Richter F, et al. Coronavirus 2019 and people living with Human Immunodeficiency Virus: outcomes for hospitalized patients in New York City. Clin Infect Dis. 2020;71:2933–8.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Crane HM, McCaul ME, Chander G, Hutton H, Nance RM, Delaney JAC, et al. Prevalence and Factors Associated with Hazardous Alcohol Use among persons living with HIV across the US in the current era of antiretroviral treatment. AIDS Behav. 2017;21:1914–25.PubMedPubMedCentralCrossRef Crane HM, McCaul ME, Chander G, Hutton H, Nance RM, Delaney JAC, et al. Prevalence and Factors Associated with Hazardous Alcohol Use among persons living with HIV across the US in the current era of antiretroviral treatment. AIDS Behav. 2017;21:1914–25.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Shiau S, Arpadi SM, Yin MT, Martins SS. Patterns of drug use and HIV infection among adults in a nationally representative sample. Addict Behav. 2017;68:39–44.PubMedPubMedCentralCrossRef Shiau S, Arpadi SM, Yin MT, Martins SS. Patterns of drug use and HIV infection among adults in a nationally representative sample. Addict Behav. 2017;68:39–44.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and Drug Use among Human Immunodeficiency virus–infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–8.PubMedCrossRef Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and Drug Use among Human Immunodeficiency virus–infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–8.PubMedCrossRef
9.
Zurück zum Zitat Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and Adherence to Antiretroviral Therapy in Low-, Middle- and high-income countries: a systematic review and Meta-analysis. Curr HIV/AIDS Rep. 2014;11:291–307.PubMedPubMedCentralCrossRef Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and Adherence to Antiretroviral Therapy in Low-, Middle- and high-income countries: a systematic review and Meta-analysis. Curr HIV/AIDS Rep. 2014;11:291–307.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Brandt C, Zvolensky MJ, Woods SP, Gonzalez A, Safren SA, O’Cleirigh CM. Anxiety symptoms and disorders among adults living with HIV and AIDS: a critical review and integrative synthesis of the empirical literature. Clin Psychol Rev. 2017;51:164–84.PubMedCrossRef Brandt C, Zvolensky MJ, Woods SP, Gonzalez A, Safren SA, O’Cleirigh CM. Anxiety symptoms and disorders among adults living with HIV and AIDS: a critical review and integrative synthesis of the empirical literature. Clin Psychol Rev. 2017;51:164–84.PubMedCrossRef
11.
Zurück zum Zitat Duko B, Ayalew M, Ayano G. The prevalence of alcohol use disorders among people living with HIV/AIDS: a systematic review and meta-analysis. Subst Abuse Treat Prev Policy. 2019;14:52.PubMedPubMedCentralCrossRef Duko B, Ayalew M, Ayano G. The prevalence of alcohol use disorders among people living with HIV/AIDS: a systematic review and meta-analysis. Subst Abuse Treat Prev Policy. 2019;14:52.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of Age-Associated comorbidities and their risk factors between HIV-Infected and uninfected individuals: the AGEhIV Cohort Study. Clin Infect Dis. 2014;59:1787–97.PubMedCrossRef Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of Age-Associated comorbidities and their risk factors between HIV-Infected and uninfected individuals: the AGEhIV Cohort Study. Clin Infect Dis. 2014;59:1787–97.PubMedCrossRef
13.
Zurück zum Zitat Calina D, Hartung T, Mardare I, Mitroi M, Poulas K, Tsatsakis A, et al. COVID-19 pandemic and alcohol consumption: impacts and interconnections. Toxicol Rep. 2021;8:529–35.PubMedPubMedCentralCrossRef Calina D, Hartung T, Mardare I, Mitroi M, Poulas K, Tsatsakis A, et al. COVID-19 pandemic and alcohol consumption: impacts and interconnections. Toxicol Rep. 2021;8:529–35.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Kitahata MM, Rodriguez B, Haubrich R, Boswell S, Mathews WC, Lederman MM, et al. Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. Int J Epidemiol. 2008;37:948–55.PubMedPubMedCentralCrossRef Kitahata MM, Rodriguez B, Haubrich R, Boswell S, Mathews WC, Lederman MM, et al. Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. Int J Epidemiol. 2008;37:948–55.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Crane MH, Lober W, Webster E, Harrington DR, Crane KP, Davis ET, et al. Routine Collection of patient-reported outcomes in an HIV Clinic setting:the First 100 patients. Curr HIV Res. 2007;5:109–18.PubMedCrossRef Crane MH, Lober W, Webster E, Harrington DR, Crane KP, Davis ET, et al. Routine Collection of patient-reported outcomes in an HIV Clinic setting:the First 100 patients. Curr HIV Res. 2007;5:109–18.PubMedCrossRef
16.
Zurück zum Zitat Rudolph JE, Cole SR, Edwards JK, Moore R, O’Cleirigh C, Mathews WC, et al. At-Risk Alcohol Use among HIV-Positive patients and the completion of patient-reported outcomes. AIDS Behav. 2018;22:1313–22.PubMedPubMedCentralCrossRef Rudolph JE, Cole SR, Edwards JK, Moore R, O’Cleirigh C, Mathews WC, et al. At-Risk Alcohol Use among HIV-Positive patients and the completion of patient-reported outcomes. AIDS Behav. 2018;22:1313–22.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Higgins-Biddle JC, Babor TF. A review of the Alcohol Use disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: past issues and future directions. Am J Drug Alcohol Abuse. 2018;44:578–86.PubMedPubMedCentralCrossRef Higgins-Biddle JC, Babor TF. A review of the Alcohol Use disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: past issues and future directions. Am J Drug Alcohol Abuse. 2018;44:578–86.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114:163–73.PubMedCrossRef Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114:163–73.PubMedCrossRef
20.
Zurück zum Zitat Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, et al. Validation of the Alcohol, Smoking and Substance involvement screening test (ASSIST). Addiction. 2008;103:1039–47.PubMedCrossRef Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, et al. Validation of the Alcohol, Smoking and Substance involvement screening test (ASSIST). Addiction. 2008;103:1039–47.PubMedCrossRef
21.
Zurück zum Zitat Spitzer RL, Kroenke K, Williams JBW, the Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MDThe PHQ primary care study. JAMA. 1999;282:1737–44.PubMedCrossRef Spitzer RL, Kroenke K, Williams JBW, the Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MDThe PHQ primary care study. JAMA. 1999;282:1737–44.PubMedCrossRef
22.
Zurück zum Zitat Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317–25.PubMedCrossRef Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317–25.PubMedCrossRef
23.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH, (Lucy) Zhang Y, Castro AF, Feldman HI, et al. A New equation to Estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12. Levey AS, Stevens LA, Schmid CH, (Lucy) Zhang Y, Castro AF, Feldman HI, et al. A New equation to Estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
24.
Zurück zum Zitat Bender Ignacio RA, Shapiro AE, Nance RM, Whitney BM, Delaney J, Bamford L et al. Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. medRxiv: the preprint server for health sciences. 2021; :2021.12.07.21267296. Bender Ignacio RA, Shapiro AE, Nance RM, Whitney BM, Delaney J, Bamford L et al. Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. medRxiv: the preprint server for health sciences. 2021; :2021.12.07.21267296.
25.
Zurück zum Zitat Howe CJ, Cole SR, Westreich DJ, Greenland S, Napravnik S, Eron JJJ. Splines for trend analysis and continuous confounder control. Epidemiology. 2011;22:874–5.PubMedPubMedCentralCrossRef Howe CJ, Cole SR, Westreich DJ, Greenland S, Napravnik S, Eron JJJ. Splines for trend analysis and continuous confounder control. Epidemiology. 2011;22:874–5.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Stuart EA, Azur M, Frangakis C, Leaf P. Multiple imputation with large data sets: a case study of the children’s Mental Health Initiative. Am J Epidemiol. 2009;169:1133–9.PubMedPubMedCentralCrossRef Stuart EA, Azur M, Frangakis C, Leaf P. Multiple imputation with large data sets: a case study of the children’s Mental Health Initiative. Am J Epidemiol. 2009;169:1133–9.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Singh GK, Kim IE, Girmay M, Perry C, Daus GP, Vedamuthu IP, et al. Opioid epidemic in the United States: empirical trends, and a Literature Review of Social Determinants and Epidemiological, Pain Management, and treatment patterns. Int J MCH AIDS. 2019;8:89–100.PubMedPubMedCentralCrossRef Singh GK, Kim IE, Girmay M, Perry C, Daus GP, Vedamuthu IP, et al. Opioid epidemic in the United States: empirical trends, and a Literature Review of Social Determinants and Epidemiological, Pain Management, and treatment patterns. Int J MCH AIDS. 2019;8:89–100.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Witkiewitz K, Vowles KE, Alcohol, Use O. Co-use, and Chronic Pain in the context of the opioid epidemic: a critical review. Alcoholism: Clin Experimental Res. 2018;42:478–88.CrossRef Witkiewitz K, Vowles KE, Alcohol, Use O. Co-use, and Chronic Pain in the context of the opioid epidemic: a critical review. Alcoholism: Clin Experimental Res. 2018;42:478–88.CrossRef
30.
Zurück zum Zitat Fojo AT, Lesko CR, Calkins KL, Moore RD, McCaul ME, Hutton HE, et al. Do symptoms of Depression interact with Substance Use to affect HIV Continuum of Care outcomes? AIDS Behav. 2019;23:580–91.PubMedPubMedCentralCrossRef Fojo AT, Lesko CR, Calkins KL, Moore RD, McCaul ME, Hutton HE, et al. Do symptoms of Depression interact with Substance Use to affect HIV Continuum of Care outcomes? AIDS Behav. 2019;23:580–91.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Lesko CR, Hutton HE, Edwards JK, McCaul ME, Fojo AT, Keruly JC, et al. Alcohol Use Disorder and recent Alcohol Use and HIV viral non-suppression among people engaged in HIV Care in an urban clinic, 2014–2018. AIDS Behav. 2022;26:1299–307.PubMedCrossRef Lesko CR, Hutton HE, Edwards JK, McCaul ME, Fojo AT, Keruly JC, et al. Alcohol Use Disorder and recent Alcohol Use and HIV viral non-suppression among people engaged in HIV Care in an urban clinic, 2014–2018. AIDS Behav. 2022;26:1299–307.PubMedCrossRef
32.
Zurück zum Zitat Westreich D, Edwards JK, Tennant PWG, Murray EJ, van Smeden M. Choice of Outcome in COVID-19 studies and implications for Policy: Mortality and Fatality. Am J Epidemiol. 2022;191:282–6.PubMedCrossRef Westreich D, Edwards JK, Tennant PWG, Murray EJ, van Smeden M. Choice of Outcome in COVID-19 studies and implications for Policy: Mortality and Fatality. Am J Epidemiol. 2022;191:282–6.PubMedCrossRef
33.
Zurück zum Zitat Saurabh S, Verma MK, Gautam V, Kumar N, Jain V, Goel AD, et al. Tobacco, alcohol use and other risk factors for developing symptomatic COVID-19 vs asymptomatic SARS-CoV-2 infection: a case–control study from western Rajasthan, India. Trans R Soc Trop Med Hyg. 2021;115:820–31.PubMedCrossRef Saurabh S, Verma MK, Gautam V, Kumar N, Jain V, Goel AD, et al. Tobacco, alcohol use and other risk factors for developing symptomatic COVID-19 vs asymptomatic SARS-CoV-2 infection: a case–control study from western Rajasthan, India. Trans R Soc Trop Med Hyg. 2021;115:820–31.PubMedCrossRef
34.
Zurück zum Zitat Allen HK, Cohen-Winans S, Armstrong K, Clark NC, Ford MA. COVID-19 exposure and diagnosis among college student drinkers: links to alcohol use behavior, motives, and context. Translational Behav Med. 2021;11:1348–53.CrossRef Allen HK, Cohen-Winans S, Armstrong K, Clark NC, Ford MA. COVID-19 exposure and diagnosis among college student drinkers: links to alcohol use behavior, motives, and context. Translational Behav Med. 2021;11:1348–53.CrossRef
35.
Zurück zum Zitat Zamboanga BL, Blumenthal H, Ramarushton B, Napper LE, Hurlocker MC, Ford K, et al. What pandemic? A multisite study of drinking motives and drinking games participation among college students during a pandemic (COVID-19) academic year. Addict Behav. 2023;138:107560.PubMedCrossRef Zamboanga BL, Blumenthal H, Ramarushton B, Napper LE, Hurlocker MC, Ford K, et al. What pandemic? A multisite study of drinking motives and drinking games participation among college students during a pandemic (COVID-19) academic year. Addict Behav. 2023;138:107560.PubMedCrossRef
36.
Zurück zum Zitat Jolley SE, Alkhafaf Q, Hough C, Welsh DA. Presence of an alcohol use disorder is associated with greater pneumonia severity in hospitalized HIV-infected patients. Lung. 2016;194:755–62.PubMedPubMedCentralCrossRef Jolley SE, Alkhafaf Q, Hough C, Welsh DA. Presence of an alcohol use disorder is associated with greater pneumonia severity in hospitalized HIV-infected patients. Lung. 2016;194:755–62.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Romeo J, Wärnberg J, Nova E, Díaz LE, Gómez-Martinez S, Marcos A. Moderate alcohol consumption and the immune system: a review. Br J Nutr. 2007;98:111–S115.CrossRef Romeo J, Wärnberg J, Nova E, Díaz LE, Gómez-Martinez S, Marcos A. Moderate alcohol consumption and the immune system: a review. Br J Nutr. 2007;98:111–S115.CrossRef
38.
Zurück zum Zitat Choi NG, DiNitto DM. Heavy/binge drinking and depressive symptoms in older adults: gender differences. Int J Geriatr Psychiatry. 2011;26:860–8.PubMedCrossRef Choi NG, DiNitto DM. Heavy/binge drinking and depressive symptoms in older adults: gender differences. Int J Geriatr Psychiatry. 2011;26:860–8.PubMedCrossRef
39.
Zurück zum Zitat Bilal U, McCaul ME, Crane HM, Mathews WC, Mayer KH, Geng E, et al. Predictors of longitudinal trajectories of alcohol consumption in people with HIV. Alcoholism: Clin Experimental Res. 2018;42:561–70.CrossRef Bilal U, McCaul ME, Crane HM, Mathews WC, Mayer KH, Geng E, et al. Predictors of longitudinal trajectories of alcohol consumption in people with HIV. Alcoholism: Clin Experimental Res. 2018;42:561–70.CrossRef
40.
Zurück zum Zitat Sydén L, Wennberg P, Forsell Y, Romelsjö A. Stability and change in alcohol habits of different socio-demographic subgroups-a cohort study. BMC Public Health. 2014;14:1–12.CrossRef Sydén L, Wennberg P, Forsell Y, Romelsjö A. Stability and change in alcohol habits of different socio-demographic subgroups-a cohort study. BMC Public Health. 2014;14:1–12.CrossRef
41.
Zurück zum Zitat Jehn A, Stackhouse M, Zajacova A. COVID-19 Health precautions: identifying demographic and Socio-Economic disparities and changes over Time. Can Public Policy. 2021;47:252–64.PubMedPubMedCentralCrossRef Jehn A, Stackhouse M, Zajacova A. COVID-19 Health precautions: identifying demographic and Socio-Economic disparities and changes over Time. Can Public Policy. 2021;47:252–64.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Barr T, Helms C, Grant K, Messaoudi I. Opposing effects of alcohol on the immune system. Prog Neuropsychopharmacol Biol Psychiatry. 2016;65:242–51.PubMedCrossRef Barr T, Helms C, Grant K, Messaoudi I. Opposing effects of alcohol on the immune system. Prog Neuropsychopharmacol Biol Psychiatry. 2016;65:242–51.PubMedCrossRef
43.
Zurück zum Zitat Pollard MS, Tucker JS, Green HD Jr. Changes in adult Alcohol Use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3:e2022942–2.PubMedPubMedCentralCrossRef Pollard MS, Tucker JS, Green HD Jr. Changes in adult Alcohol Use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3:e2022942–2.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Hu Y, Quigley BM, Taylor D. Human mobility data and machine learning reveal geographic differences in alcohol sales and alcohol outlet visits across US states during COVID-19. PLoS ONE. 2021;16:e0255757.PubMedPubMedCentralCrossRef Hu Y, Quigley BM, Taylor D. Human mobility data and machine learning reveal geographic differences in alcohol sales and alcohol outlet visits across US states during COVID-19. PLoS ONE. 2021;16:e0255757.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Lesko CR, Keil AP, Moore RD, Chander G, Fojo AT, Lau B. Measurement of current substance use in a cohort of HIV-Infected persons in continuity HIV Care, 2007–2015. Am J Epidemiol. 2018;187:1970–9.PubMedPubMedCentralCrossRef Lesko CR, Keil AP, Moore RD, Chander G, Fojo AT, Lau B. Measurement of current substance use in a cohort of HIV-Infected persons in continuity HIV Care, 2007–2015. Am J Epidemiol. 2018;187:1970–9.PubMedPubMedCentralCrossRef
Metadaten
Titel
Association of Alcohol Use with COVID-19 Infection and Hospitalization Among People Living with HIV in the United States, 2020
verfasst von
Chunyi Xia
Geetanjali Chander
Heidi E. Hutton
Mary E. McCaul
Joseph A. Delaney
Kenneth H. Mayer
Jeffrey M. Jacobson
Sarah Puryear
Heidi M. Crane
Adrienne E. Shapiro
Edward R. Cachay
Bryan Lau
Sonia Napravnik
Michael Saag
Catherine R. Lesko
Publikationsdatum
29.02.2024
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 5/2024
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-024-04301-6

Weitere Artikel der Ausgabe 5/2024

AIDS and Behavior 5/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.